Relating to the regulation of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and registrations; imposing fees; creating criminal offenses; authorizing an administrative penalty.

89th Legislature, 1st Called Session (2025) Introduced by Paul Bettencourt and 10 co-sponsors

SB 5 requires Texas hemp product manufacturers and sellers to obtain licenses, pay fees, and comply with regulations or face criminal charges and penalties.

Received from the Senate

#business&commerce--tradepractices(i0006) #crimes--drugs(i0185) #fees&othernontaxrevenue--state(i0362) #health&humanservicescommission(v0177) #hemp(s0907) #health--general(i0385) #minors--crimesagainst(i0532) #minors--health&safety(i0533) #occupationalregulation--othertrades&professions(i0541) #packaging&labelingrequirements(s0339) #statehealthservices #departmentof(v0463)

Legislative bill overview

SB 5 establishes a comprehensive regulatory framework for hemp-derived products in Texas, requiring manufacturers and sellers of consumable hemp products and hemp-derived cannabinoids (like Delta-8 and Delta-10 THC) to obtain occupational licenses and registrations. The bill imposes licensing fees, creates new criminal offenses for non-compliance, and authorizes administrative penalties for violators.

Why is this important

Hemp-derived cannabinoids currently exist in a legal gray area in Texas, creating an unregulated market with inconsistent product quality, safety standards, and potency labeling. This bill aims to bring the booming hemp products industry under state oversight, similar to how other states regulate cannabis products, while generating state revenue through licensing fees and protecting consumers from unlicensed sellers.

Potential points of contention

Federal-state legal conflict: Hemp-derived cannabinoids occupy murky federal legal territory; this regulation could conflict with federal interpretations or create liability issues for businesses operating under conflicting guidance

Small business impact: Licensing requirements and fees may burden small retailers and online sellers, potentially consolidating the market toward larger corporations with compliance resources

Criminal penalties scope: The bill creates new criminal offenses without clearly defining thresholds—unclear what conduct triggers prosecution versus administrative penalties, potentially leading to inconsistent enforcement

Consumer access vs. public health: Regulation may reduce access to these products for some users while others argue insufficient evidence exists on safety and long-term effects to warrant licensing a booming industry